TOKIO–(BUSINESS WIRE)–Un método innovador de trasplante de células para tratar enfermedades del endotelio corneal, tales como la queratopatía bullosa, utilizando una lámina de gel nanocompuesto desarrollado por científicos japoneses fue patentado en …
Category: Business
Sight Sciences to Present at 31st Annual Piper Jaffray Healthcare Conference
MENLO PARK, Calif.–(BUSINESS WIRE)–Sight Sciences, Inc., a growth-stage medical device company transforming the two fastest growing segments in ophthalmology and optometry, glaucoma and dry eye disease, today announced that the company’s management i…
Ocular Therapeutix™ to Present at the Piper Jaffray 31st Annual Healthcare Conference
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today a…
IVERIC bio to Present at Evercore ISI 2nd Annual HealthCONx Conference
NEW YORK–(BUSINESS WIRE)–IVERIC bio announced that Glenn Sblendorio, CEO and President, will present a Company overview at the Evercore ISI 2nd Annual HealthCONx Conference.
Riassunto: GN CORPORATION: restituita la vista con un trapianto di cellule corneali grazie a una tecnica a nano-strati; brevetto rilasciato a una società giapponese in India
TOKYO–(BUSINESS WIRE)–Un innovativo metodo di trapianto cellulare per il trattamento delle patologie dell’endotelio corneale come la cheratopatia bollosa, usando uno strato di gel nanocomposito sviluppato da scienziati giapponesi, ha ottenuto il brev…
GN CORPORATION: Wiederherstellung der Sehkraft durch Transplantation von Hornhautzellen mithilfe einer Nanoblatt-Technik; japanische Firma erhält Patent in Indien
TOKIO (Japan)–(BUSINESS WIRE)–Eine neuartige Methode zur Zelltransplantation ermöglicht die Behandlung von Erkrankungen des Hornhautendothels, zum Beispiel der bullösen Keratopathie, mit einem von japanischen Wissenschaftlern entwickelten Nanoverbund…
Global Contact Lenses Market Review and Outlook, 2016-2019 & 2027 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Contact Lenses Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019-2027” report has been added to ResearchAndMarkets.com’s offering. The contact lenses market report provides analysis for the …
Just in Time for Black Friday: Stanton Optical, a Leading Eye Care Provider, Debuts Retail Store in Wichita
WICHITA, Kan.–(BUSINESS WIRE)– #BlackFriday–Stanton Optical, a retail brand of Now Optics, leading eye care provider, opened its first store in Wichita, Kansas at 438 S. Rock Rd.
Just in Time for Black Friday: Stanton Optical, a Leading Eye Care Provider, Debuts Retail Store in Springfield
SPRINGFIELD, Mo.–(BUSINESS WIRE)– #BlackFriday–Stanton Optical, a retail brand of Now Optics, a leading eye care provider, opened its first store in Springfield, Missouri.
ProtoKinetix AAGP® Dry Eye Therapy Program Launched
MARIETTA, Ohio–(BUSINESS WIRE)– #AAGP–ProtoKinetix AAGP® Dry Eye Therapy Program Launched
Glaukos Completes Acquisition of Avedro, Inc.
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that …
EnChroma Makes New Indoor Color Blind Glasses Available to the Public
BERKELEY, Calif.–(BUSINESS WIRE)– #colorishere–New EnChroma® Cx1 Indoor DT glasses offer an improved indoor lens designed specifically for Deutan-type color blindness
Horizon Therapeutics plc Launches New Online Community Connecting People Living with Thyroid Eye Disease and Urging them to “Listen to Your Eyes”
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics today announced the launch of a new online community for people living with thyroid eye disease called “Listen to Your Eyes.”
Ocular Therapeutix™ to Present at the Jefferies 2019 London Healthcare Conference
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today a…
Armenian EyeCare Project Surpasses Milestone of 10,000 Patients Screened Using Artificial Intelligence Eye Screening Technology
YEREVAN, Armenia–(BUSINESS WIRE)–On this World Diabetes Day, the Armenian EyeCare Project (AECP), a nonprofit organization dedicated to eliminating preventable blindness in Armenia, announced that it has surpassed the milestone of screening 10,000 pa…
Aadi Bioscience Breakthrough Therapy nab-Sirolimus (ABI-009) Independent Reviewed Data Released from the AMPECT Registration Trial in Advanced PEComa
PACIFIC PALISADES, Calif.–(BUSINESS WIRE)–Aadi Bioscience, Inc. (Aadi), a privately held clinical stage biopharmaceutical company, today released its independent radiology reviewed data from the nab-sirolimus (ABI-009) registration trial (AMPECT) for…
MJH Life Sciences™ Publications Win Big at 2019 Folio: Eddie and Ozzie Awards Gala
CRANBURY, N.J.–(BUSINESS WIRE)– #FolioAwards–Three MJH Life Sciences™ Publications won first place across a range of categories at this year’s Folio: Eddie and Ozzie Awards gala
ELT Sight Acquires Assets and IP of MLase AG Excimer Ophthalmic Laser System for Glaucoma Surgery
LOS ANGELES & MUNICH–(BUSINESS WIRE)–ELT Sight acquires assets and IP of MLase AG excimer ophthalmic laser system for implant-free microinvasive glaucoma surgery.
Aerie Pharmaceuticals to Present at the Stifel 2019 Healthcare Conference
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
IVERIC bio Reports Third Quarter 2019 Operational Highlights and Financial Results
NEW YORK–(BUSINESS WIRE)–IVERIC bio today provided an overview of the Company’s financial results for the third quarter 2019 and provided a general business update.